Nanogen Pharmaceutical Biotechnology

Nanogen Pharmaceutical Biotechnology Patent applications

Patent application number

Title

Published

20130230490

PEG-Interferon Lambda 1 Conjugates - The present application discloses new PEG-interferon lambda 1 conjugates (PEG-IFNλ1), processes for their preparation, pharmaceutical compositions containing these conjugates and processes for making the same. These conjugates have increased blood half-lives and persistence time compared to IFNλ1 and are effective in the treatment of hepatitis B and hepatitis C.